Divalent Cations Differentially Regulate Integrin αIIb Cytoplasmic Tail Binding to β3 and to Calcium- and Integrin-binding Protein*
- Laurent Vallar‡,
- Chantal Melchior‡,
- Sébastien Plançon‡,
- Hervé Drobecq§,
- Guy Lippens§,
- Véronique Regnault¶ and
- Nelly Kieffer‡‖
- From the ‡Laboratoire Franco-Luxembourgeois de Recherche Biomédicale (CNRS and CRP-Santé), Centre Universitaire, L-1511 Luxembourg, Grand Duchy of Luxembourg, the§Institut de Biologie de Lille, Laboratoire de RMN, F-59000 Lille, France, and the ¶Laboratoire d’Hématologie, UMR CNRS 7563, Faculté de Médecine, F-54500 Vandoeuvre-lès-Nancy, France
Abstract
We have used recombinant or synthetic αIIb and β3 integrin cytoplasmic peptides to study their in vitro complexation and ligand binding capacity by surface plasmon resonance. α·β heterodimerization occurred in a 1:1 stoichiometry with a weakK D in the micromolar range. Divalent cations were not required for this association but stabilized the α·β complex by decreasing the dissociation rate. α·β complexation was impaired by the R995A substitution or the KVGFFKR deletion in αIIb but not by the β3 S752P mutation. Recombinant calcium- and integrin-binding protein (CIB), an αIIb-specific ligand, bound to the αIIbcytoplasmic peptide in a Ca2+- or Mn2+-independent, one-to-one reaction with aK D value of 12 μm. In contrast,in vitro liquid phase binding of CIB to intact αIIbβ3 occurred preferentially with Mn2+-activated αIIbβ3conformers, as demonstrated by enhanced coimmunoprecipitation of CIB with PAC-1-captured Mn2+-activated αIIbβ3, suggesting that Mn2+activation of intact αIIbβ3 induces the exposure of a CIB-binding site, spontaneously exposed by the free αIIb peptide. Since CIB did not stimulate PAC-1 binding to inactive αIIbβ3 nor prevented activated αIIbβ3 occupancy by PAC-1, we conclude that CIB does not regulate αIIbβ3 inside-out signaling, but rather is involved in an αIIbβ3 post-receptor occupancy event.
Footnotes
-
↵* This work was supported by grants from Centre de Recherche Public-Santé (CRP-Santé, Luxembourg), CNRS (France), Fondation Luxembourgeoise Contre le Cancer (Luxembourg), and EC Biomed-Project Grant BMH4-CT98-3517.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵‖ To whom correspondence should be addressed: Laboratoire Franco-Luxembourgeois de Recherche Biomédicale, (CNRS and CRP-Santé), Centre Universitaire, 162A Ave. de la Faı̈encerie, L-1511 Luxembourg, Grand Duchy of Luxembourg. Tel.: 352-466644-440; Fax: 352-466644-442; E-mail: kieffer{at}cu.lu.
- Abbreviations:
- CIB
-
calcium- and integrin-binding protein
- CHO
-
Chinese hamster ovary
- ConA
-
concanavalin A
- GST
-
glutathione S-transferase
- HEL
-
human erythroleukemia
- HPLC
-
high performance liquid chromatography
- mAb
-
monoclonal antibody
- PAGE
-
polyacrylamide gel electrophoresis
- PBS
-
phosphate-buffered saline
- PCR
-
polymerase chain reaction
- RT-PCR
-
reverse transcriptase-polymerase chain reaction
- RU
-
resonance unit
- SPR
-
surface plasmon resonance
- TBS
-
Tris-buffered saline
- ELISA
-
enzyme-linked immunosorbent assay
- Tricine
-
N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine
-
- Received January 27, 1999.
- Revision received March 16, 1999.
- The American Society for Biochemistry and Molecular Biology, Inc.











